Arata Corporation · TSE:2733
Arata — Q3 FY2024 Earnings Presentation
12 slides from Arata's earnings presentation, February 2025
Slide 1: ARATA Corporation Q3 of Fiscal Year Ending March 2025 Financial Results
NOTICE The slides in this presentation has been translated using a mechanical automatic translation service. In some cases, the translation may be inaccurate or unintended. Please use this service with the understanding that translations are not always accurate. ARATA Corporation Q3 of Fiscal Year E
Slide 2: Q3 FY03/2025 Highlights
Q3 FY03/2025 results ■ Q3 FY03/2025 Highlights ・ Sales growth in the H&B and Pet categories ・ Sales growth due to expansion of new transactions ・ Improve Gross profit by expanding H&B categories ・ Increase in SG&A expenses due to increase in Logistics and Personnel expenses In Q3 FY03/2025 Net sales
Slide 3: Consolidated Statements of Income
Q3 FY03/2025 results ■ Consolidated Statements of Income Q3 Q3 Progress FY03/2024 FY03/2025 YoY change rate Planning (Millions of JPY) Results Results Change Rate (%) Rate (%) Net sales 719,119 754,500 35,381 104.9 969,000 77.9 Gross profit 70,589 74,454 3,864 105.5 ‐ ‐ SG&A expenses 58,161 61,354 3
Slide 4: Q3 FY03/2025 Factors: Net sales record highs
Q3 FY03/2025 results ■ Q3 FY03/2025 Factors Net sales: Record highs achieved for the 10th consecutive year Net Sales : JPY754.5 billion YoY: +JPY35.381 billion 104.9% Q3 FY03/2025 Cumulative Net sales YoY 104.9% ・ Success of existing focus categories (H&B and pets) ・ Expand sales of exclusive and pr
Slide 5: Factors: Ordinary income record highs achieved
Q3 FY03/2025 results ■ Q3 FY03/2025 Factors Ordinary income: Record highs achieved Ordinary income: JPY13.777 billion YoY: +JPY778 million 106.0% Gross profit : JPY74.454 billion YoY: +JPY3.864 billion 105.5% Gross margin: 9.87% YoY +0.05 points ・ Strong sales of exclusive cosmetics and other produc
Slide 6: Sales by Category (YoY)
Q3 FY03/2025 results ■ Sales by Category (YoY) (Millions of JPY) 250,000 233,267 221,509 Q3 FY03/2024 200,000 Q3 FY03/2025 105.3% 143,128 143,012 150,000 134,442 136,894 105.9% 110,071 106.5% 103,950 100,000 104.5% 104.8% 60,556 99.6% 57,808 48,682 48,899 101.1% 50,000 15,782 15,613 0 H&B Pets Paper
Slide 7: Net Sales by Business Category (YoY)
Q3 FY03/2025 results ■ Net Sales by Business Category (YoY) (Millions of JPY) 390,590 400,000 376,454 Q3 FY03/2024 103.8% Q3 FY03/2025 300,000 200,000 107.4% 101,932 109,474 101.8% 110.2% 100,000 84,148 110.5% 81,672 82,646 74,079 58,943 96.8% 53,348 30,658 29,671 0 Drugstores DIY store Supermarket
Slide 8: Consolidated Balance Sheets
Q3 FY03/2025 results ■ Consolidated Balance Sheets FY03/2024 Q3 FY03/2025 (Millions of JPY) (Millions of JPY) Current assets Current Current assets Current 242,745 liabilities 280,586 liabilities 170,647 203,874 76.6% 53.8% 79.4% 57.7% Long‐term 36,609 Long‐term 35,489 liabilities 11.6% liabilities
Slide 9: Consolidated Statements of Income (Accounting period)
Q3 FY03/2025 results ■ Consolidated Statements of Income (Accounting period) Q1 Q2 Q3 YoY change YoY change YoY change (Millions of JPY) FY03/2024 FY03/2025 FY03/2024 FY03/2025 FY03/2024 FY03/2025 Rate (%) Rate (%) Rate (%) Net sales 235,239 245,604 104.4 236,148 245,918 104.1 247,730 262,978 106.2
Slide 10: Year-end targets and progress
Q3 FY03/2025 results ■ Year‐end targets and progress Progress of year‐end targets YoY of Cumulative Q3 Results YoY of year‐end targets Cumulative Q3 Cumulative Q3 Cumulative Q3 YoY YoY FY03/2025 Progress FY03/2024 FY03/2025 FY03/2024 FY03/2024 FY03/2025 change change (Millions of JPY) Year‐end targe
Slide 11: Summary: Aim to increase profit
Q3 FY03/2025 results ■ Q3 FY03/2025 Summary ・ Record highs for Net sales, Operating income, and Ordinary income in cumulative Q3 ・ Record high for Q3 accounting period →Steady growth due to sales expansion and profit improvement Toward the Achievement of Year‐End Targets FY03/2025 Year‐end target Ne
Slide 12: Cautionary Statement with Respect to Forward-Looking Statements
Cautionary Statement with Respect to Forward‐Looking Statements This material is solely for information purposes and should not be construed as a solicitation. This document (including the performance plan) has been prepared by us based on reliable information currently available, but it involves